Načítá se...
The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic
Esophageal adenocarcinoma (EAC) is a poor prognosis cancer type with rapidly rising incidence. Our understanding of genetic events that drive EAC development is limited, and there are few molecular biomarkers for prognostication or therapeutics. Using a cohort of 551 genomically characterized EACs w...
Uloženo v:
| Vydáno v: | Nat Genet |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6420087/ https://ncbi.nlm.nih.gov/pubmed/30718927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41588-018-0331-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|